Clinical Trial: A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

U.S., June 30 -- ClinicalTrials.gov registry received information related to the study (NCT07674654) titled 'A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine' on June 15.

Brief Summary: This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Acute Migraine

Intervention: DRUG: Elismetrep

Administered orally

DRUG: Placebo

Administered orally

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kallyope Inc.

Disclaimer: Curated by HT Syndication....